Effects of oral meso-2, 3-dimercaptosucinic acid (DMSA) administration on late gestation and postnatal development in the mouse
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 47 (19), 1745-1750
- https://doi.org/10.1016/0024-3205(90)90348-u
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- MESO-2,3-Dimercaptosuccinic Acid: Chemical, Pharmacological and Toxicological Properties of an Orally Effective Metal Chelating AgentAnnual Review of Pharmacology and Toxicology, 1990
- Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoningClinical Biochemistry, 1989
- Influence of 2,3-dimercaptosuccinic acid on gastrointestinal lead absorption and whole-body lead retentionToxicology and Applied Pharmacology, 1989
- Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrationsThe Journal of Pediatrics, 1988
- Management of childhood lead poisoningThe Journal of Pediatrics, 1984
- DMSA and DMPS-Water Soluble Antidotes for Heavy Metal PoisoningAnnual Review of Pharmacology and Toxicology, 1983
- Biological chelation: 2,3-dimercapto-propanesulfonic acid and meso-dimercaptosuccinic acidAdvances in Enzyme Regulation, 1982
- THE EFFECTS OF DIMERCAPTOSUCCINIC ACID ON THE EXCRETION AND DISTRIBUTION OF MERCURY IN RATS AND MICE TREATED WITH MERCURIC CHLORIDE AND METHYLMERCURY CHLORIDEBritish Journal of Pharmacology, 1976
- The use of chelating agents in the treatment of acute and chronic lead intoxication in childhoodThe Journal of Pediatrics, 1968
- British Anti-Lewisite (BAL)Nature, 1945